Krishna Doshi,MD (@Krishnahdoshi) profile picture

Hematology and Oncology Fellow @UTHSA| No medical advice

Joined December 2024
Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)Photo by Krishna Doshi,MD (@Krishnahdoshi)
Hem/Onc Fellowship orientation is underway! We’re so excited to welcome the incoming first year fellows! @HemOncFellows @DrSAHaddad @mayscancer @DanielaUruetamd @theglpman @OscarAndreHino1 @AnumjalilMD @Krishnahdoshi @KateIdaLathrop
3
2
8
1,668
Krishna Doshi,MD retweeted
Not that I need to add but this is a truly historic moment - the kind we all work for. Kudos to all. And for our patients. @OncoAlert
Incredible #ASCO26 moment. Dr. Brian Wolpin, presenter of the daraxonrasib study, received a standing ovation DURING his talk after he stated the survival benefit for PDAC patients. It was sustained. Cheering. I have never see anything like it in the middle of a talk. $RVMD
3
18
100
7,821
Krishna Doshi,MD retweeted
You don’t have to be a GI oncologist to appreciate this moment. #ASCO2026
5
42
6
407
20,406
Krishna Doshi,MD retweeted
@jonescolton242 investigates chemoprevention in #crc with GLP-1s #coloncancerawarenessmonth
GLP-1 medications are widely used to treat diabetes and support weight loss. At @uthealthsa, Colton Jones, MD, is investigating whether GLP-1 medications could play a role in reducing colorectal cancer incidence. magazines.uthscsa.edu/missio…
2
6
10
1,461
Krishna Doshi,MD retweeted
So proud of lead author @coltonjones presenting his research at #GI26 This week! @mayscancer @UTHealthSA Ozempic, Wegovy Might Lower Colon Cancer Risk usnews.com/news/health-news/…
4
2
9
1,553
Krishna Doshi,MD retweeted
Check out full abstracts for #GI26! See you at @ASCO GI this week!
Abstracts for #GI26 now available! Discover emerging treatment modalities, the latest clinical trial results, advances in precision medicine, and more—all in the field of gastrointestinal cancers. View the abstracts: brnw.ch/21wYQVp #gicsm #OncTwitter
3
8
803
Beyond proud of @Krishnahdoshi on her poster presentation on real world data on the impact of PT/OT referrals on lymphedema at @SABCSSanAntonio! Also my first poster presentation as a senior author! #SABCS25 @mayscancer @LSOM_HemOnc @HemOncFellows @oncodaily @OncoAlert
4
1
14
829
Krishna Doshi,MD retweeted
We show for the first time that a high-fiber diet is a low-risk intervention that may delay progression to myeloma. This project is truly team science and an amazing collaborative effort that spans multiple institutions, 3 countries and 7 years. #ASH25 #mmsm
1
5
2
30
4,714
A big congrats to all the newly matched 2025 Hem/Onc fellows! 🩺 We are so excited to have you join our program! #Match2025 #HemeOnc @Krishnahdoshi @mayscancer @HemOncFellows
1
2
1
27
4,036
As #SIOG2025 nears its close, one message stands out: 🌍 The world is ageing—and we must be ready to treat older adults with #cancer. 💙 Thank you to everyone driving this mission forward. #25YearsOfSIOG #GeriatricOncology #HealthyAgeing
7
20
682
Absolutely honored to have 3/3 poster presentations accepted at #SABCS25 including a senior author poster presentation with my amazing mentee @Krishnahdoshi ! @LSOM_HemOnc @mayscancer @UTHSAResearch @HemOncFellows @hemeoncfellow @oncodaily @HemOncWomenDocs
4
3
29
1,596
Krishna Doshi,MD retweeted
📢 Have you read our new @ASCO Global Geriatric Oncology Guidelines yet? They provide resource-stratified recommendations to improve cancer care for older adults worldwide 🌍👵🧓 Read & download the full manuscript here 👉 doi.org/10.1200/GO-25-00276 #gerionc #globonc #ASCOGuidelines
2
23
1
39
3,249
Fantastic news for patients! OS benefit with adjuvant abemaciclib for 2 years for high-risk node positive patients. Congratulations to everyone involved with the monarchE trial. Awaiting details at an upcoming meeting. HTTPS://prn.to/3JRHsS4
11
19
2
54
5,310
✨ Excited to share our manuscript is published in Am J Hospice & Palliative Medicine! “Nationwide Trends & Disparities in End-of-Life Care for AML: 2019–2021 NIS Analysis.” 📖 Read here: journals.sagepub.com/eprint/… #AML #Palliativecare #HealthEquity
2
11
1,029
Olanzapine for Anorexia in Patients With Incurable #Cancer and #Cachexia (OlAnCa): A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. jnccn.org/view/journals/jncc… @JNCCN @CancerCachexia #CancerResearch #PallOnc #SuppOnc #CancerCare
2
39
2
104
10,858
Excited to be presenting our research at the ASCO Quality Care Symposium this October in Chicago! Grateful to @imranputhawala @anuja_abhyankar @MacNealIMRP for the support. Look forward to the discussions on quality and equity in cancer care. @IMG_Oncologists @oncodaily
3
3
2
22
3,254
5
26
1
66
9,663
Krishna Doshi,MD retweeted
SPEAKER ANNOUNCEMENT!📣 Register today for the 2026 ASCL Conference in San Antonio, Texas and hear from @DrSukeshiArora. Find more information at latinocancer.com! #ASCL206 #LatinoCancer2026
5
1
9
857
Thanks to @SuzanneColeMD of @UTSouthwestern for interviewing with me for @oncodaily’s podcast - #EMPOWERINGONCOLOGISTS ✅Great insights as to how you established a research infrastructure in a community setting. ✅how you navigated through life making choices that were not the usual but very apt for your career and personal life trajectory. ✅And how leadership can bring its own challenges and you successfully handled them and utilized coaching as a tool. @HemOncFellows @HemOncWomenDocs @IMG_Oncologists @oncologyCOA youtu.be/gzeql_MMkJ0?si=pVLv…
5
16
810
Krishna Doshi,MD retweeted
The first controlled trial of hydroxyurea in hemoglobin #SickleCell disease shows reductions in vaso-occlusive episodes and hospitalizations, though safety non-inferiority wasn’t met. 🔗ow.ly/RBRO50VHqxN #Hematology
6
14
2,026